Citigroup
CRL icon

Citigroup’s Charles River Laboratories CRL Stock Holding History

Citigroup’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,000
Closed -$2.9M – 7624
2019
Q4 		$2.9M Buy
+19,000
New +$2.63M ﹤0.01% 2580

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Citigroup's CRL Position: Q2 2026 in Review

Citigroup increased its Charles River Laboratories (CRL) stake by 289% in Q2 2026, buying an estimated $41.8M and bringing the position to 316,217 shares worth $71.7M. The position accounts for 0.02% of the portfolio, ranked #593.

Citigroup first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Citigroup held 316,217 shares of Charles River Laboratories worth $71.7M as of Q2 2026.
  • Citigroup bought 234,906 Charles River Laboratories shares in Q2 2026, an estimated $41.8M.
  • Charles River Laboratories made up 0.02% of Citigroup's portfolio in Q2 2026, its #593 holding.
  • Citigroup first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.